Kinkel, R Philip <br/><br/>
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.  [electronic resource] 

 -  Neurology  Mar 2006 
 - 678-84 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000200778.65597.ae  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Demyelinating Diseases--drug therapy<br/>Follow-Up Studies<br/>Humans<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Multiple Sclerosis--classification<br/>Recurrence<br/>Regression Analysis<br/>Time Factors<br/>Treatment Outcome